InnoCare Pharma Limited (HKG: 9969)
Hong Kong
· Delayed Price · Currency is HKD 5.60
-0.09 (-1.58%)
Jan 3, 2025, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 11.67 billion as of January 3, 2025. Its market cap has decreased by -5.27% in one year.
Market Cap
11.67B
Enterprise Value
5.56B
Revenue
995.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.60
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has decreased from 12.28B to 11.67B, a decrease of -4.97%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 11.67B | -7.67% |
| Dec 31, 2024 | 12.64B | -7.61% |
| Dec 29, 2023 | 13.68B | -44.57% |
| Dec 30, 2022 | 24.68B | 7.55% |
| Dec 31, 2021 | 22.95B | 32.04% |
| Dec 31, 2020 | 17.38B | 41.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 149.74B |
| Hansoh Pharmaceutical Group Company | 98.87B |
| JD Health International | 84.92B |
| WuXi Biologics | 68.94B |
| Sinopharm Group | 64.91B |
| Innovent Biologics | 58.07B |
| Sino Biopharmaceutical | 55.71B |
| CSPC Pharmaceutical Group | 53.23B |